The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 47-60

  Cole, Toby B ^a   Jansen, Karen ^a   Park, Sarah ^a   Li, Wan Fen ^a   Furlong, Clement E ^a   Costa, Lucio G ^a  

^a NONE

Author keywords

Carboxylesterase; Chlorpyrifos; Chlorpyrifos oxon; Diazinon; Diazoxon; Malaoxon; Malathion; Mixed exposures; Paraoxon; Paraoxonase 1 (PON1); Parathion; Pyrethroids; Tricresyl phosphate

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CARBOXYLESTERASE; CHLORPYRIFOS; DIAZOXON; MALAOXON; ORGANOPHOSPHATE; ORGANOPHOSPHORUS COMPOUND; PARAOXON; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; DETOXIFICATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GENETIC POLYMORPHISM; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; INSECTICIDE RESISTANCE; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CARBOXYLESTERASE; CHLORPYRIFOS; DISEASE MODELS, ANIMAL; GENOTYPE; INSECTICIDES; MICE; MICE, KNOCKOUT; ORGANOPHOSPHORUS COMPOUNDS; PARAOXON; TISSUE DISTRIBUTION;

MUS; MUS MUSCULUS;

EID: 77956550126     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_6     Document Type: Article

References (74)

1. Abernathy CO, Casida JE (1973) Pyrethroid insecticides: esterase cleavage in relation to selective toxicity. Science 179:1235-1236
2. Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 53:598-608 (Pubitemid 23311330)
3. Aldridge WN (1954) Tricresyl phosphates and cholinesterase. Biochem J 56:185-189
4. Buratti FM, Testai E (2005) Malathion detoxication by human hepatic carboxylesterase and its inhibition by isomalathion and other pesticides. J Biochem Mol Toxicol 19:406-414 (Pubitemid 43139753)
5. Casida JE, Eto M, Baron RL (1961) Biological activity of a tri-o-cresyl phosphate metabolite. Nature 191:1396-1397
6. Casida JE, Baron RL, Eto M, Engel JL (1963) Potentiation and neurotoxicity induced by certain organophosphates. Biochem Pharmacol 12:73-83
7. Chambers HW, Brown B, Chambers JE (1990) Noncatalytic detoxication of six organophosphorus compounds by rat liver homogenates. Pestic Biochem Physiol 36:308-315 (Pubitemid 20274656)
8. Chambers JE, Ma T, Boone JS, Chambers HW (1994) Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. Life Sci 54:1357-1364 (Pubitemid 24131429)
9. Chen PR, Tucker WP, Dauterman WC (1969) Structure of biologically produced malathion monoacid. J Agr Food Chem 17:86-90
10. Choi J, Hodgson E, Rose RL (2004) Inhibition of transpermethrin hydrolysis in human liver fractions by chloropyrifos oxon and carbaryl. Drug Metabol Drug Interact 20:233-246 (Pubitemid 40083057)
11. Cohen SD, Murphy SD (1971a) Malathion potentiation and inhibition of hydrolysis of various carboxylic esters by triorthotolyl phosphate (TOTP) in mice. Biochem Pharmacol 20:575-587
12. Cohen SD, Murphy SD (1971b) Carboxylesterase inhibition as an indicator of malathion potentiation in mice. J Pharmacol Exp Ther 176:733-742
13. Cohen SD, Callaghan JE, Murphy SD (1972) Investigation of multiple mechanisms for potentiation of malaoxon's anticholinesterase action by triorthotolyl phosphate. Proc Soc Exp Biol Med 141:906-910
14. Cole TB, Jampsa RL, Walter BJ, Arndt TA, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, Furlong CE (2003) Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364 (Pubitemid 36724529)
15. Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, Richter RJ, Costa LG (2005) Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics 15:589-598. (Pubitemid 41044245)
16. Cook JW, Blake JR, Williams MW(1957) Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. J Assess Office Agr Chem 40:664
17. Cook JW, Yip G (1958) Malathionase. II. Identity of a malathion metabolite. J Assess Office Agr Chem 41:407-411
18. Costa LG, McDonald BE, Murphy SD, Omenn GS, Richter RJ, Motulsky AG, Furlong CE (1990) Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. Toxicol Appl Pharmacol 103:66-76 (Pubitemid 20115985)
19. Costa LG, Li W-F, Richter RJ, Shih DM, Lusis AJ, Furlong CE (1999) The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Chem Biol Interact 119-120:429-438 (Pubitemid 29278580)
20. Costa LG (2006) Current issues in organophosphate toxicology. Clin Chim Acta 366:1-13 (Pubitemid 43330962)
21. Davies H, Richter RJ, Kiefer M, Broomfield C, Sowalla J, Furlong CE (1996) The human serum paraoxonase polymorphism is reversed with diazinon, soman and sarin. Nat Genet 14: 334-336.
22. DuBois KP, Doull J, Deroin J, Cumming OR (1953) Studies on the toxicity and mechanism of action of some new insecticidal thionophosphates. Arch Ind Hyg Occup Med 8:350-358
23. DuBois KP (1958) Potentiation of toxicity of insecticidal organophosphates. Arch Industr Health 18:488-496
24. DuBois KP (1969) Combined effects of pesticides. Canad Med Assoc J 100:173-179
25. Ellman GL, Courtney KD, Andres VJ, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
26. Eskenazi B, Rosas LG, Marks AR, Bradman A, Harley K, Holland N, Johnson C, Fenster L, Barr DB (2008) Pesticide toxicity and the developing brain. Basic Clin Pharmacol Toxicol 102:228-236 (Pubitemid 351143428)
27. Fenske RA, Lu C, Curl CL, Shirai JH, Kissel JC (2005) Biologic monitoring to characterize organophosphorus pesticide exposure among children and workers: an analysis of recent studies in Washington State. Environ Health Perspect 113:1651-1657 (Pubitemid 41614926)
28. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays fro the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242-247 (Pubitemid 19198054)
29. Furlong CE, Costa LG, Hassett C, Richter RJ, Sundstrom JA, Adler DA, Disteche CM, Omiecinski CJ, Chapline C, Crabb JW (1993) Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol Interact 87:35-48 (Pubitemid 23205360)
30. Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B (2006) PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 16:183-190
31. Furlong CE (2007) Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J Biochem Mol Toxicol 21:197-205 (Pubitemid 350194380)
32. Furlong CE, Richter RJ, Li W-F, Brophy VH, Carlson C, Meider M, Nickerson D, Costa LG, Ranchalis J, Lusis AJ, Shih DM, Tward A, Jarvik GP (2008) The functional consequences of polymorphisms in the human PON1 gene. In: Mackness B, Mackness M, Aviram M, Paragh G (Eds). The Paraoxonases: Their Role in Disease, Development and Xenobiotic Metabolism. Dordrecht, The Netherlands: Springer, pp. 267-281
33. Gaughan LC, Engel JL, Casida JE (1980) Pesticide interactions: effects of organophosphorus pesticides on the metabolism, toxicity, and persistence of selected pyrethroid insecticides. Pestic Biochem Physiol 14:81-85 (Pubitemid 11190757)
34. Godin SJ, Crow JA, Scollon EJ, Hughes MF, DeVito MJ, Ross MK (2007) Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides Deltamethrin and Esfenvalerate. Drug Metab Dispos 35:1664-1671 (Pubitemid 47296062)
35. Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE (1991) Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30:10141-10149
36. Hosokawa M, Endo T, Fujisawa M, Hara S, Iwata N, Sato Y, Satoh T (1995) Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab Dispos 23:1022-1027
37. Huen K, Richter R, Furlong C, Eskenazi B, Holland N (2009) Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta 402(1-2):67-74
38. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73-76 (Pubitemid 23063292)
39. Jansen KL, Cole TB, Park S, Furlong CE, Costa LG (2009) Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol 236(2):142-153
40. Jarvik GP, Jampsa R, Richter RJ, Carlson CS, RiederMJ, Nickerson DA, Furlong CE (2003) Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13:291-295 (Pubitemid 36583997)
41. Li WF, Costa LG, Furlong CE (1993) Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health 40:337-346 (Pubitemid 23344358)
42. Li WF, Furlong CE, Costa LG (1995) Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 76:219-226
43. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE (2000) Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 10:767-799
44. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70:1673-1684 (Pubitemid 41540360)
45. Lu C, Toepel K, Irish R, Fenske RA, Barr DB, Bravo R (2006) Organic diets significantly lower children's dietary exposure to organophosphorus pesticides. Environ Health Perspect 114: 260-263 (Pubitemid 43193649)
46. Main AR (1956) The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can J Biochem Physiol 34:197-216
47. Main AR, Dauterman WC (1967) Kinetic for the inhibition of carboxylesterase by malaoxon. Can J Biochem 45:757-771
48. March RB, Fukuto TR, Metcalf RL, Moxon MG (1956) Fate of P32 labelled malathion in the laying hen, white mouse and American cockroach. J Econ Entomol 49:185-195
49. Moser VC, Casey M, Hamm A, CarterWHJr, Simmons JE, Gennings C (2005) Neurotoxicological and statistical analyses of a mixture of five organophosphorus pesticides using a ray design. Toxicol Sci 86:101-115 (Pubitemid 41511355)
50. Moser VC, Simmons JE, Gennings C (2006) Neurotoxicological interactions of a five-pesticide mixture in preweanling rats. Toxicol Sci 92:235-245 (Pubitemid 43985806)
51. Munger JS, Shi GP, Mark EA, Chin DT, Gerard C, Chapman HA (1991) A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem 266:18832-18838 (Pubitemid 21908159)
52. Murphy SD, DuBois KP (1957) Quantitative measurement of inhibition of the enzymatic detoxification of malathion by EPN (ethyl p-nitrophenyl thionobenzene phosphate). Proc Soc Exp Biol Med 96:813-818
53. Murphy SD, Anderson RL, DuBois KP (1959) Potentiation of toxicity of malathion by triorthotolyl phosphate. Proc Soc Exp Biol Med 100:483-487
54. O'Brien RD (1957) Properties and metabolism in the cockroach and mouse of malathion and malaoxon. J Econ Entomol 50:1159-1164
55. Pond AL, Chambers HW, Coyne CP, Chambers JE (1998) Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon. J Pharmacol Exp Ther 286:1404-1411 (Pubitemid 29135555)
56. Ramakrishna N, Ramachandran BV (1978) Malathion A and B esterases of mouse liver-III: In vivo effect of parathion and related PNP-containing insecticides on esterase inhibition and potentiation of malathion toxicity. Biochem Pharmacol 27:2049-2054 (Pubitemid 9043858)
57. Richter RJ, Furlong CE (1999) Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9:745-753 (Pubitemid 30011938)
58. Richter RJ, Jarvik GP, Furlong CE (2008) Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet 1:147-152
59. Richter RJ, Jarvik GP, Furlong CE (2009) Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol 235(1):1-9
60. Satoh T, Hosokawa M (2006) Structure, function and regulation of carboxylesterases. Chem Biol Interact 162:195-211 (Pubitemid 44402409)
61. Seume FW, O'Brien RD (1960) Potentiation of toxicity to insects and mice of phosphorothionates containing carboxyester and carboxyamide groups. Toxicol Appl Pharmacol 2: 495-503
62. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287 (Pubitemid 28335041)
63. Stevens RC, Suzuki SM, Cole TB, Park SS, Richter RJ, Furlong CE (2008) Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc Natl Acad Sci USA 105:12780-12784
64. Su MQ, Kinoshita FK, Frawley JP, DuBois KP (1971) Comparative inhibition of aliesterases and cholinesterase in rats fed eighteen organophosphorus insecticides. Toxicol Appl Pharmacol 20:241-249
65. Tang J, Cao Y, Rose RL, Brimfield AA, Dai D, Goldstein JA, Hodgson E (2001) Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos 29:1201-1204 (Pubitemid 32800231)
66. Tang J, Chambers JE (1999) Detoxication of paraoxon by rat liver homogenate and serum carboxylesterases and A-esterases. J Biochem Mol Toxicol 13:261-268 (Pubitemid 129705401)
67. Timchalk C, Poet TS, Hinman MN, Busby AL, Kousba AA (2005) Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat. Toxicol Appl Pharmacol 205:31-42 (Pubitemid 40693267)
68. US Environmental Protection Agency (1999) Policy on a Common Mechanism of Action: The Organophosphate Pesticides. Fed Regist 64(24):5795-5799
69. US Environmental Protection Agency (2002) Organophosphate pesticides: Revised OP cumulative risk assessment. www.epa.gov/pesticides/cumulative/rra-op/
70. US Environmental Protection Agency (2006) Organophosphorus Cumulative Risk Assessment- 2006 Update. Technical Executive Summary. US EPA Office of Pesticide Programs. www. epa. gov/oppsrrd1/cumulative/2006-op/
71. Verschoyle RD, Reiner E, Bailey E, Aldridge WN (1982) Dimethylphosphorothioates. Reaction with malathion and effect on malathion toxicity. Arch Toxicol 49:293-301
72. Wheelock CE, Eder KJ, Werner I, Huang H, Jones PD, Brammell BF, Elskus AA, Hammock BD (2005) Individual variability in esterase acticity and CYP1A levels in Chinook salmon (Oncorhynchus tshawytscha) exposed to esfenvalerate and chlorpyrifos. Aquat Toxicol 74: 172-192 (Pubitemid 41073739)
73. Williams FM, Mutch EM, Nicholson E, Wynne E, Wright P, Lambert D, Rawlins MD (1989) Human liver and plasma aspirin esterase. J Pharm Pharmacol 41:407-409 (Pubitemid 19175236)
74. Winder C, Balouet JC (2002) The toxicity of commercial jet oils. Environ Res 89:146-164 (Pubitemid 34680884)